Cellectis (CLLS) Interest Coverage Ratio (2015 - 2026)
Cellectis' (CLLS) quarterly Interest Coverage Ratio came in at 5.66 in Q1 2026, up 309.23% year-on-year from 1.38 in Q1 2025, and up 3060.88% quarter-over-quarter from 0.19 in Q4 2025.
Cellectis (CLLS) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
Cellectis' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 5.66 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 309.23% year-over-year to 5.66 in Q1 2026; TTM through Mar 2026 was 0.79, a 94.96% increase from a year earlier, with the FY2025 full-year figure at 1.17, up 57.67% from the prior year.
- Interest Coverage Ratio grew to 5.66 in Q1 2026 per CLLS's latest filing, from 0.19 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 25.14 in Q3 2022 and bottomed at 1.1 in Q2 2023.
- The 5-year median for Interest Coverage Ratio is 0.7 (2024), against an average of 4.67.
- Across the five-year window, Interest Coverage Ratio tumbled 205.43% in 2025 and jumped 309.23% in 2026, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.26 in 2022, then sank by 80.04% to 0.46 in 2023, then jumped by 49.61% to 0.23 in 2024, then gained by 18.22% to 0.19 in 2025, then jumped by 3060.88% to 5.66 in 2026.
- Per Business Quant, the three latest CLLS Interest Coverage Ratio figures stand at 5.66 (Q1 2026), 0.19 (Q4 2025), and 0.74 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 5.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.66 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 1.38 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 1.03 |
| Mar 31, 2024 | 6.66 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -0.90 |
| Jun 30, 2023 | -1.10 |
| Mar 31, 2023 | 4.53 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | 25.14 |
| Jun 30, 2022 | 16.15 |
| Mar 31, 2022 | 21.52 |
| Dec 31, 2021 | -4.29 |
| Sep 30, 2021 | -19.37 |
| Jun 30, 2021 | 28.57 |